• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病(COPD)患者住院急性加重期细菌学病因的前瞻性研究:与肺功能和呼吸衰竭的关系

A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure.

作者信息

Kuwal Ashok, Joshi Vinod, Dutt Naveen, Singh Surjit, Agarwal Kailash Chand, Purohit Gopal

机构信息

Department of Pulmonary Medicine, Pacific Institute of Medical Sciences, Udaipur, Rajasthan, India.

Department of Pulmonary Medicine, Institute of Respiratory Diseases (IRD), SMS Medical College, Jaipur, Rajasthan, India.

出版信息

Turk Thorac J. 2018 Jan;19(1):19-27. doi: 10.5152/TurkThoracJ.2017.17035. Epub 2017 Nov 29.

DOI:10.5152/TurkThoracJ.2017.17035
PMID:29404182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5783049/
Abstract

OBJECTIVES

Bacterial infections are the major cause of acute exacerbation of COPD (AE-COPD). The relationship between lung functions and respiratory failure (arterial blood gas parameters) with the etiology of AE-COPD has not been clearly understood. We conducted this study to determine the bacterial profile in AE-COPD and to identify the associated risk factors and drug sensitivity pattern.

MATERIAL AND METHODS

Seventy-two patients hospitalized for AE-COPD were prospectively evaluated. Quantitative sputum culture, blood gas analysis, and drug sensitivity testing were performed at the time of admission, and pulmonary function testing was performed 6 weeks after discharge as per standard guidelines.

RESULTS

Bacterial pathogens were isolated in 34 (47.22%) cases. Pathogens isolated were (38.23%), (29.41%), (23.53%), (5.88%), and spp. (2.94%). Isolation of bacterial pathogen was observed in patients with advancing age (p=0.02), frequent exacerbations (p<0.001), systemic steroid use (p=0.005), and deranged lung function (p=0.02). Binary logistic regression analysis revealed that higher partial pressure of carbon dioxide (PaCO2) was independently associated with isolation of (p=0.025) and (p=0.001). Additional independent factors that favor isolation of were age >55 years (p=0.017) and systemic steroid use (p=0.017). Antibiotic sensitivity testing showed that ciprofloxacin and piperacillin/tazobactum were effective in 27/34 (79.41%) of isolates followed by gentamycin in 26/34 (76%).

CONCLUSION

Hypercapnic respiratory failure is an independent risk factor for isolation of and in addition to advanced age and systemic steroid use. These findings may be an important adjunct in deciding the initial antibiotic therapy.

摘要

目的

细菌感染是慢性阻塞性肺疾病急性加重(AE-COPD)的主要原因。AE-COPD的病因与肺功能及呼吸衰竭(动脉血气参数)之间的关系尚未完全明确。我们开展本研究以确定AE-COPD中的细菌谱,并识别相关危险因素及药敏模式。

材料与方法

对72例因AE-COPD住院的患者进行前瞻性评估。入院时进行定量痰培养、血气分析及药敏试验,并按照标准指南在出院6周后进行肺功能测试。

结果

34例(47.22%)患者分离出细菌病原体。分离出的病原体有肺炎链球菌(38.23%)、流感嗜血杆菌(29.41%)、卡他莫拉菌(23.53%)、金黄色葡萄球菌(5.88%)及其他菌种(2.94%)。在年龄较大(p=0.02)、频繁急性加重(p<0.001)、使用全身性激素(p=0.005)及肺功能紊乱(p=0.02)的患者中观察到细菌病原体分离。二元逻辑回归分析显示,较高的二氧化碳分压(PaCO2)与肺炎链球菌(p=0.025)及流感嗜血杆菌(p=0.001)的分离独立相关。有利于肺炎链球菌分离的其他独立因素为年龄>55岁(p=0.017)及使用全身性激素(p=0.017)。药敏试验表明,环丙沙星和哌拉西林/他唑巴坦对27/34(79.41%)的分离株有效,其次是庆大霉素对26/34(76%)的分离株有效。

结论

除高龄和使用全身性激素外,高碳酸血症性呼吸衰竭是肺炎链球菌和流感嗜血杆菌分离的独立危险因素。这些发现可能是决定初始抗生素治疗的重要辅助依据。

相似文献

1
A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure.慢性阻塞性肺疾病(COPD)患者住院急性加重期细菌学病因的前瞻性研究:与肺功能和呼吸衰竭的关系
Turk Thorac J. 2018 Jan;19(1):19-27. doi: 10.5152/TurkThoracJ.2017.17035. Epub 2017 Nov 29.
2
Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.台湾慢性阻塞性肺疾病急性加重住院患者的痰液细菌学,重点关注肺炎克雷伯菌和铜绿假单胞菌。
Respirology. 2007 Jan;12(1):81-7. doi: 10.1111/j.1440-1843.2006.00999.x.
3
Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study.慢性阻塞性肺疾病急性加重需要住院治疗的患者的细菌感染:一项为期1年的前瞻性研究。
Respir Med. 2003 Jul;97(7):770-7. doi: 10.1016/s0954-6111(03)00026-x.
4
A prediction model for bacterial etiology in acute exacerbations of COPD.慢性阻塞性肺疾病急性加重期细菌病因的预测模型。
Infection. 2007 Jun;35(3):143-9. doi: 10.1007/s15010-007-6078-z.
5
Infectious etiology of acute exacerbations in severe COPD patients.严重 COPD 患者急性加重的感染病因。
J Infect. 2013 Dec;67(6):516-23. doi: 10.1016/j.jinf.2013.09.003. Epub 2013 Sep 20.
6
COPD Exacerbation-Related Pathogens and Previous COPD Treatment.慢性阻塞性肺疾病急性加重相关病原体与既往慢性阻塞性肺疾病治疗情况
J Clin Med. 2022 Dec 23;12(1):111. doi: 10.3390/jcm12010111.
7
Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD.慢性阻塞性肺疾病急性加重期患者痰液中细菌菌群与功能损害的关系。慢性阻塞性肺疾病细菌感染研究组。
Chest. 1999 Jul;116(1):40-6. doi: 10.1378/chest.116.1.40.
8
16S rDNA-based metagenomic analysis of dental plaque and lung bacteria in patients with severe acute exacerbations of chronic obstructive pulmonary disease.基于16S核糖体DNA的慢性阻塞性肺疾病严重急性加重患者牙菌斑和肺部细菌宏基因组分析
J Periodontal Res. 2014 Dec;49(6):760-9. doi: 10.1111/jre.12159. Epub 2014 Feb 1.
9
Bacteriological differences between COPD exacerbation and community-acquired pneumonia.COPD 加重期与社区获得性肺炎的细菌学差异。
Respir Care. 2011 Nov;56(11):1818-24. doi: 10.4187/respcare.00915. Epub 2011 May 20.
10
Regional specifics of microbial landscape in outpatients with lower respiratory tract infections.下呼吸道感染门诊患者微生物群落的区域特征
Int J Risk Saf Med. 2015;27 Suppl 1:S61-2. doi: 10.3233/JRS-150691.

引用本文的文献

1
Immunological Insights and Therapeutic Advances in COPD: Exploring Oral Bacterial Vaccines for Immune Modulation and Clinical Improvement.慢性阻塞性肺疾病的免疫学见解与治疗进展:探索用于免疫调节和临床改善的口服细菌疫苗
Vaccines (Basel). 2025 Jan 22;13(2):107. doi: 10.3390/vaccines13020107.
2
COPD Exacerbation-Related Pathogens and Previous COPD Treatment.慢性阻塞性肺疾病急性加重相关病原体与既往慢性阻塞性肺疾病治疗情况
J Clin Med. 2022 Dec 23;12(1):111. doi: 10.3390/jcm12010111.
3
Trends in the Bacterial Prevalence and Antibiotic Resistance Patterns in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Hospitalized Patients in South India.印度南部住院患者慢性阻塞性肺疾病急性加重期的细菌流行趋势及抗生素耐药模式
Antibiotics (Basel). 2022 Nov 9;11(11):1577. doi: 10.3390/antibiotics11111577.
4
Bacterial Isolates and Antibacterial Resistance Patterns in a Patient with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in a Tertiary Teaching Hospital, Southwest Ethiopia.埃塞俄比亚西南部一家三级教学医院中一名慢性阻塞性肺疾病急性加重患者的细菌分离株及抗菌药物耐药模式
Can J Infect Dis Med Microbiol. 2022 Aug 31;2022:9709253. doi: 10.1155/2022/9709253. eCollection 2022.
5
Pathogens Isolated and Their Association With the Long-Term Outcome in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病急性加重患者分离出的病原体及其与长期预后的关系
Cureus. 2022 Jun 21;14(6):e26174. doi: 10.7759/cureus.26174. eCollection 2022 Jun.
6
Eosinopenia as a biomarker for antibiotic use in COPD exacerbations: protocol for a retrospective hospital-based cohort study.嗜酸性粒细胞减少作为 COPD 加重期抗生素使用的生物标志物:一项基于回顾性医院队列研究的方案。
BMJ Open. 2022 Jan 20;12(1):e051939. doi: 10.1136/bmjopen-2021-051939.
7
Molecular Mechanisms of Lipid Metabolism Disorders in Infectious Exacerbations of Chronic Obstructive Pulmonary Disease.脂质代谢紊乱在慢性阻塞性肺疾病感染加重中的分子机制。
Int J Mol Sci. 2021 Jul 17;22(14):7634. doi: 10.3390/ijms22147634.
8
Clinical efficacy of ceftazidime combined with levofloxacin on heart failure complicated with pulmonary infection and its influence on cardiopulmonary function.头孢他啶联合左氧氟沙星治疗心力衰竭合并肺部感染的临床疗效及其对心肺功能的影响
Am J Transl Res. 2021 Apr 15;13(4):2590-2598. eCollection 2021.
9
Study of respiratory viruses and their coinfection with bacterial and fungal pathogens in acute exacerbation of chronic obstructive pulmonary diseases.慢性阻塞性肺疾病急性加重期呼吸道病毒及其与细菌和真菌病原体合并感染的研究
Lung India. 2021 Jan-Feb;38(1):53-58. doi: 10.4103/lungindia.lungindia_273_20.
10
The Value of Inflammatory Biomarkers in Differentiating Asthma-COPD Overlap from COPD.炎症生物标志物在鉴别哮喘-慢性阻塞性肺疾病重叠综合征与慢性阻塞性肺疾病中的价值
Int J Chron Obstruct Pulmon Dis. 2020 Nov 20;15:3025-3037. doi: 10.2147/COPD.S273422. eCollection 2020.

本文引用的文献

1
Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期细菌学结果的决定因素
Infection. 2016 Feb;44(1):65-76. doi: 10.1007/s15010-015-0833-3. Epub 2015 Sep 14.
2
Chronic exposure to glucocorticoids shapes gene expression and modulates innate and adaptive activation pathways in macrophages with distinct changes in leukocyte attraction.慢性暴露于糖皮质激素会影响巨噬细胞的基因表达,并调节先天和适应性激活途径,导致白细胞吸引的明显变化。
J Immunol. 2014 Feb 1;192(3):1196-208. doi: 10.4049/jimmunol.1302138. Epub 2014 Jan 6.
3
Spectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of China.中国内地慢性阻塞性肺疾病急性加重期患者分离的常见病原菌的分布及耐药性分析。
Chin Med J (Engl). 2013 Jun;126(12):2207-14.
4
Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH).印度成人哮喘、呼吸道症状和慢性支气管炎的流行病学研究(INSEARCH)。
Int J Tuberc Lung Dis. 2012 Sep;16(9):1270-7. doi: 10.5588/ijtld.12.0005.
5
Microbiological study of patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) and the usefulness of analytical and clinical parameters in its identification (VIRAE study).慢性阻塞性肺疾病(AE-COPD)急性加重住院患者的微生物学研究及其分析和临床参数在其识别中的作用(VIRAE 研究)。
Int J Chron Obstruct Pulmon Dis. 2012;7:327-35. doi: 10.2147/COPD.S30568. Epub 2012 May 25.
6
Susceptibility to exacerbation in chronic obstructive pulmonary disease.慢性阻塞性肺疾病恶化的易感性。
N Engl J Med. 2010 Sep 16;363(12):1128-38. doi: 10.1056/NEJMoa0909883.
7
Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study.铜绿假单胞菌在 COPD 加重住院患者中的作用:一项前瞻性研究。
Eur Respir J. 2009 Nov;34(5):1072-8. doi: 10.1183/09031936.00003309. Epub 2009 Apr 22.
8
Role of bacteria in acute exacerbations of chronic obstructive pulmonary disease.细菌在慢性阻塞性肺疾病急性加重中的作用。
Int J Chron Obstruct Pulmon Dis. 2008;3(3):463-7. doi: 10.2147/copd.s2776.
9
Pseudomonas aeruginosa in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的铜绿假单胞菌
Am J Respir Crit Care Med. 2008 Apr 15;177(8):853-60. doi: 10.1164/rccm.200709-1413OC. Epub 2008 Jan 17.
10
A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD.一项针对慢性阻塞性肺疾病急性加重期住院患者感染病因的为期1年的前瞻性研究。
Chest. 2007 Jan;131(1):44-52. doi: 10.1378/chest.06-1355.